EULAR recommendations for the treatment of systemic sclerosis: 2023 update

2024175 citationsJournal Articlehybrid Open Access

Authors

Francesco Del Galdo · Leeds Teaching Hospitals NHS Trust

Alain Lescoat · Université de Rennes

Philip G. Conaghan · NIHR Leeds Musculoskeletal Biomedical Research Unit

Eugenia Bertoldo · University of Verona

Jelena Čolić · University of Belgrade

Tânia Santiago · Hospitais da Universidade de Coimbra

Yossra A. Suliman

Abstract

These updated recommendations include the first set of synthetic and biological targeted therapies recommended for key fibrotic manifestations of SSc as well as first-line combination treatment for newly diagnosed pulmonary artery hypertension and prioritise a new research agenda for the coming years.

Topics & Keywords

Systemic Sclerosis and Related Diseases Dermatologic Treatments and Research Connective Tissue Growth Factor Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of the Rheumatic Diseases

Volume 84, Issue 1, pp. 29-40

DOI: 10.1136/ard-2024-226430

Field-Weighted Citation Impact: 73.60